Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E2F transcription factor 6 pseudogene 4 (E2F6P4) is a genomic locus classified as a pseudogene, meaning it is related by sequence homology to the E2F transcription factor gene family (specifically E2F6) but typically does not encode a functional protein[1][3]. Pseudogenes are generally considered remnants of gene evolution and are not transcribed or translated into functional molecules, nor are they considered direct therapeutic targets. E2F6P4 is located on chromosome X at position Xq26.3[3]. Its main relevance is in genomic studies or as a sequence-based marker, but it has no established biological function as a transcription factor, receptor, enzyme, or other therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E2F transcription factor 6 pseudogene 4 (E2F6P4).